Pay in 4 interest-free payments of $6.39 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
When you decide to supplement, the goal is to provide your body with a consistent supply that it can actually use
Two caveats temper the result: nausea occurred in 46% of lixisenatide-treated participants and vomiting in 13%, raising the possibility of functional unblinding, and the MDS-UPDRS is a clinical scale rather than a direct measure of dopaminergic neuron survival
An American owned company Disclaimer All products sold on this website under the "BACKUP" brand are non-therapeutic in nature and intended for laboratory research purposes only
By leveraging berberine's documented ability to influence cellular energy regulation and glucose metabolism, this botanical product is positioned as an accessible, scientifically backed holistic alternative to naturally manage blood sugar levels and support sustainable wellness without relying solely on synthetic pharmaceuticals In December 2025, Innovent Biologics, a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncologic, autoimmune, cardiovascular and metabolic, ophthalmologic and other major diseases, announces that the results of two Phase III clinical studies of Mazdutide, the world's first approved glucagon (GCG)/glucagon-like peptide-1 (GLP-1) dual receptor agonist, in Chinese adults with type 2 diabetes (T2D) (DREAMS-1, DREAMS-2) have been published back-to-back in Nature as Accelerated Article Previews (AAP)
151 BerndtCAlborziniaHAmenVSAytonSBarayeuUBarteltAet al
Talk to your health care provider about how your medications may interact with GLP-1 drugs
US$ 25.33
US$ 26.60
US$ 24.21
US$ 27.22
